Inflammatory myofibroblastic tumor of the larynx-a case report.
Do BA, Varshney R, Zawawi F, Levental M, Caglar D, Young J.
J Voice. 2014 Mar;28(2):258-61. doi: 10.1016/j.jvoice.2013.09.004. Epub 2013 Dec 8.
Prognostic Potential of the Expression of Podoplanin (D2-40) Within Cells of Squamous Cell Carcinoma of the Larynx and Hypopharynx.
Voelker HU, Hintermeier I, Strehl A, Scheich M.
World J Oncol. 2020 Apr;11(2):65-71. doi: 10.14740/wjon1259. Epub 2020 Mar 29.
Effect of tumor bulk on local control and survival of patients with T1 glottic cancer.
Reddy SP, Mohideen N, Marra S, Marks JE.
Radiother Oncol. 1998 May;47(2):161-6. doi: 10.1016/s0167-8140(97)00196-5.
[Analysis of clinical characteristics and treatment outcome of atypical early stage malignant laryngeal tumor].
Luo YT, Du JJ, Yu G, Jiang XJ.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Sep 20;30(18):1467-1469. doi: 10.13201/j.issn.1001-1781.2016.18.010.
[Inflammatory myofibroblastic tumor of the larynx].
Mijović Z, Mihailović D, Kostov M.
Vojnosanit Pregl. 2008 Oct;65(10):779-82. doi: 10.2298/vsp0810779m.
Dietary acrylamide and cancer risk: an updated meta-analysis.
Pelucchi C, Bosetti C, Galeone C, La Vecchia C.
Int J Cancer. 2015 Jun 15;136(12):2912-22. doi: 10.1002/ijc.29339. Epub 2014 Nov 26.
Plasmacytoma of the larynx.
Pahor AL.
J Laryngol Otol. 1978 Mar;92(3):223-32. doi: 10.1017/s0022215100085261.
Determination of BRAF V600E (VE1) protein expression and BRAF gene mutation status in codon 600 in borderline and low-grade ovarian cancers.
Sadlecki P, Walentowicz P, Bodnar M, Marszalek A, Grabiec M, Walentowicz-Sadlecka M.
Tumour Biol. 2017 May;39(5):1010428317706230. doi: 10.1177/1010428317706230.
The expression of TLR pathway molecules in peripheral blood mononuclear cells and their relationship with tumor invasion and cytokine secretion in laryngeal carcinoma.
Starska K, Forma E, Bryś M, Głowacka E, Lewy-Trenda I, Lukomski M, Krajewska WM.
Adv Med Sci. 2012 Jun 1;57(1):124-35. doi: 10.2478/v10039-011-0058-3.
Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V, Crvenkova S.
Croat Med J. 2006 Feb;47(1):42-52.
